Zobrazeno 1 - 10
of 141
pro vyhledávání: '"V, Muls"'
Autor:
M Truyens, T Lobaton, A Peeters, M Ferrante, S Vermeire, P Bossuyt, L Pouillon, P Dewint, A Cremer, H Peeters, G Lambrecht, E Louis, J F Rahier, O Dewit, V Muls, T Holvoet, L Vandermeulen, G B Gonzales, D Laukens, M De Vos
Publikováno v:
Journal of Crohn's and Colitis. 16:i029-i032
Background Fatigue is highly prevalent in patients with IBD independent of the disease status but treatment options remain limited. A potential mediator in the pathophysiology of fatigue is tryptophan (Trp), a precursor of serotonin. Recently, reduce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3ffcd3bcf738668ee8ea74fb6e0aa45
https://doi.org/10.1093/ecco-jcc/jjab232.027
https://doi.org/10.1093/ecco-jcc/jjab232.027
Publikováno v:
Journal of Crohn's and Colitis. 17:i968-i969
Background Immune-mediated inflammatory diseases (IMID) including inflammatory bowel diseases (IBD) and inflammatory arthritides are commonly treated with biological therapies, in particular anti-TNF. Patients on anti-TNF have impaired protective imm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a1478927d3e759f26fb9c30b218fa0f
https://doi.org/10.1093/ecco-jcc/jjac190.0972
https://doi.org/10.1093/ecco-jcc/jjac190.0972
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
P Bossuyt, V. Muls, D Baert, F Flamme, JC Coche, Fazia Mana, Edouard Louis, S Vanden Branden, K Wijnen, V Setakhr, Severine Vermeire, J L Coenegrachts, A Nakad, B Strubbe, F Baert, E Piters, A Vijverman, P Dolin, F D'Heygere, G Hantsbarger, A Cremer, Philip Caenepeel, Arnaud Colard, A Hantson
Publikováno v:
Journal of Crohn's and Colitis. 14:S501-S502
Background Vedolizumab (VDZ) dose optimisation (DO), by interval shortening from 8-weekly (Q8W) to 4-weekly (Q4W) dosing, is used for patients with secondary loss of response. This report presents outcome data on patients receiving DO in real-world c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b2a7a420544275b5739e90e5f5981fd0
https://doi.org/10.1093/ecco-jcc/jjz203.728
https://doi.org/10.1093/ecco-jcc/jjz203.728
Autor:
D Baert, E Piters, A Cremer, V. Muls, F D'Heygere, JC Coche, F Baert, V Setakhr, S Vanden Branden, F Flamme, Fazia Mana, P Dolin, B Strubbe, P Bossuyt, K Wijnen, Edouard Louis, A Hantson, Philip Caenepeel, Arnaud Colard, A Vijverman, Severine Vermeire, J L Coenegrachts, A Nakad
Publikováno v:
Journal of Crohn's and Colitis. 14:S503-S504
Background Clinical trials and observational studies have demonstrated the clinical efficacy of vedolizumab (VDZ) as maintenance therapy for Crohn’s disease (CD) and ulcerative colitis (UC). This report presents long-term data on persistence of VDZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccf75eb957584bbf7861dfe78e8a355a
https://doi.org/10.1093/ecco-jcc/jjz203.731
https://doi.org/10.1093/ecco-jcc/jjz203.731
Autor:
A Nakad, E Piters, F Flamme, P Bossuyt, V. Muls, P Dolin, Edouard Louis, K Wijnen, D Baert, B Jiang, A Hantson, Fazia Mana, Arnaud Colard, F Baert, A Vijverman, A Cremer, Philip Caenepeel, F Wan, V Setakhr, S Vanden Branden, B Strubbe, JC Coche, F D'Heygere, G Hantsbarger, Severine Vermeire, J L Coenegrachts
Publikováno v:
Journal of Crohn's and Colitis. 13:S153-S154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66a480cd353d2525d0b43433f3580caf
https://doi.org/10.1093/ecco-jcc/jjy222.255
https://doi.org/10.1093/ecco-jcc/jjy222.255
Autor:
Jean-François Rahier, V. Muls, Jérôme Paul, Stephanie Van Biervliet, Harald Peeters, Fernand Fontaine, Martine De Vos, Philippe Alliet, Filip Baert, Lucas Wauters, Françoise Smets, Patrick Bontems, Severine Vermeire, Geneviève Veereman, Jean-Charles Coche, Elisabeth De Greef, Tom G. Moreels, Isabelle Paquot, Peter Bossuyt, Olivier Dewit, Denis Franchimont, Edouard Louis, Els Van de Vijver, Ilse Hoffman, Bruno Hauser, W Arts
Publikováno v:
Inflammatory bowel diseases
Background: Accelerated step-up or anti-tumor necrosis factor (TNF) before first remission is currently not recommended in pediatric Crohn's disease. Methods: Five-year follow-up data from a prospective observational cohort of children diagnosed with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5c6324f61669aba1f567be74916ce33
https://hdl.handle.net/10067/1456640151162165141
https://hdl.handle.net/10067/1456640151162165141
Autor:
B. De Vroey, P Bossuyt, S Block, Catherine Reenaers, W. Van Moerkercke, V. Muls, A Cremer, P Van Hootegem, J Imschoot, A Hantson, O. Dewit
Publikováno v:
Journal of Crohn's and Colitis. 12:S476-S477
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2446ba01a6890bdadac332330e6a6f5a
https://doi.org/10.1093/ecco-jcc/jjx180.850
https://doi.org/10.1093/ecco-jcc/jjx180.850
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.